| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |